Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Last month, Medtronic (NYSE: MDT) got knocked down 3.5% on the day Boston Scientific (NYSE: BSX) lowered guidance. Normally, I'd chastise investors for painting with too broad a brush. Full Article at The Money Times
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Full Article at TransWorldNews
John Abele, Founding Chairman, Boston Scientific. View Photo »
Boston Scientific is committed to providing Japanese physicians and their patients the most innovative products and therapies ... COGNIS and TELIGEN are now part of Boston Scientific's full product portfolio in Japan, which also includes the Company's newest and most advanced pacemaker -- the ALTRUA(TM)...
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. Last month, Medtronic (NYSE: MDT) got knocked down 3.5% on the day Boston Scientific (NYSE: BSX) lowered guidance. Full Article at Motley Fool
Medtronic, Inc. (NYSE:MDT) soared 5.76% to $42.63 on 8.85 million shares after makers of artificial spinal discs, this morning fiscal second-quarter sales and profit ahead of estimates, and raised its forecast for the fiscal year. Full Article at TransWorldNews
Nov. 24 (Bloomberg) -- Medtronic Inc. , the biggest maker of heart-rhythm devices, said profit grew 59 percent, helped by sales of a new heart stent. The shares rose the most in a year after the company raised its earnings forecast. Full Article at Bloomberg.com
The Boston Scientific headquarters in Natick, Mass. , is seen Wednesday, Jan. 28, 2009. Boston Scientific says its loss widened in the fourth quarter on writedowns from its three-year-old acquisition of rival Guidant. View Photo »
This settlement allows us to focus on the remaining three companies under investigation: St. Jude Medical, Boston Scientific, and Medtronic
NATICK, Mass. , Nov. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Full Article at RedOrbit
stAnnual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2009. The company will speak at 9:00 am ET that morning. Full Article at TransWorldNews
There are no results for this module. Edit this module to change the search term used to query Wikipedia
John Abele, Founding Chairman, Boston Scientific.
View Photo »The Boston Scientific headquarters in Natick, Mass. , is seen Wednesday, Jan. 28, 2009. Boston Scientific says its loss widened in the fourth quarter on writedowns from its three-year-old acquisition of rival Guidant.
View Photo »FILE - In this Jan. 28, 2009 file photo, scientist Andrea Ippolito prepares an experiment on the effect of drugs under consideration for use in drug-coated stents on cardiovascular cells, at the Boston Scientific Research and Development lab in Natick, Mass.
View Photo »FILE - In this Jan. 28, 2009 file photo, scientist Jessica Grimsby tends to an experiment on the effect of drugs on cell growth, at the Boston Scientific Research and Development lab in Natick, Mass.
View Photo »Scientist Jessica Grimsby tends to an experiment on the effect of drugs on cell growth, at the Boston Scientific Research and Development lab in Natick, Mass. , Wednesday, Jan. 28, 2009.
View Photo »Scientist Andrea Ippolito prepares an experiment on the effect of drugs under consideration for use in drug-coated stents on cardiovascular cells, at the Boston Scientific Research and Development lab in Natick, Mass. , Wednesday, Jan. 28, 2009.
View Photo »The Boston Scientific headquarters in Natick, Mass. , is seen Wednesday, Jan. 28, 2009. Boston Scientific says its loss widened in the fourth quarter on writedowns from its three-year-old acquisition of rival Guidant.
View Photo »Boston Scientific is committed to providing Japanese physicians and their patients the most innovative products and therapies ... COGNIS and TELIGEN are now part of Boston Scientific's full product portfolio in Japan, which also includes the Company's newest and most advanced pacemaker -- the ALTRUA(TM)...
This settlement allows us to focus on the remaining three companies under investigation: St. Jude Medical, Boston Scientific, and Medtronic
We estimate that the current legislation could result in between 1,000 and 2,000 jobs lost at Boston Scientific ... It will have the effect of more than doubling our tax liability adding $150 (million) to $200 million per year.
We will have to monitor the earnings from Apple(AAPL Quote), Boston Scientific(BSX Quote), and Texas Instruments(TXN Quote), because if decent earnings numbers do not equate to stocks going higher, we have our first signal that the Usd may get bought
We are very pleased to work with with Boston Scientific ... BSC is the market leader with the resources and expertise to get the BackStop product into the hands of urologists.
Boston Scientific continues to fulfill our promise to deliver industry-leading, innovative technologies that enable physicians to best diagnose and treat digestive diseases, and enhance quality of life for patients
included such evil pharmaceutical and medical companies as Pfizer, Merck, Genzyme, Elan PLC, Eli Lilly, Becton Dickinson and Boston Scientific ... Reagan’s War.
At Boston Scientific, we are committed to delivering innovative medical technologies, and Invention Machine Goldfire is integral to our innovation and product design process ... The new software will allow us to expand deployment and empower more people so they can research customer needs efficiently an...
This award recognizes Prescient's efforts to reduce heart attack deaths using our Shield, the first product specifically designed to treat soft, vulnerable plaques ... We believe the Shield will change the treatment paradigm from repairing damage after a patient has had a heart attack to preventing plaq...
With Boston Scientific we've found an industry leader who shares our vision of improving the quality of continence care
The agreement with Bladder Health Network allows Boston Scientific to introduce health care providers to a platform specifically designed to unite treatment centers with physicians who have advanced expertise in female continence care
There are no results for this module. Edit the module to change the search term used to query Twitter.
